Secondary analysis of the DaunoDouble trial (317 adults with AML): LVEF fell during induction with no difference between daunorubicin 60 vs 90 mg/m2, but day-15 troponin T was higher with 90 mg/m2 (median 9.5 vs 7 ng/L).
Secondary analysisn = 317
Dendorfer et al. Randomized Comparison of Cardiotoxicity With 60 Versus 90 mg Daunorubicin in AML Induction Therapy